SiRNA directed against annexin II receptor inhibits angiogenesis via suppressing MMP2 and MMP9 expression

Cellular Physiology and Biochemistry

Volumn 35, Issue 3, 2015, Pages 875-884

  Song, Hongyuan ^a   Pan, Dongyan ^a   Sun, Weifeng ^a   Gu, Cao ^a   Zhang, Yuelu ^a   Zhao, Ping ^b   Qi, Zhongtian ^b   Zhao, Shihong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Annexin II receptor; C5orf39; Matrix metalloproteinase; siRNA

Indexed keywords

GELATINASE A; GELATINASE B; LIPOCORTIN 2; LIPOCORTIN 2 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; ANNEXIN II RECEPTOR, HUMAN; RECEPTOR;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL ADHESION; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; S PHASE CELL CYCLE CHECKPOINT; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; ENDOTHELIUM CELL; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHOSPHORYLATION;

ANNEXIN A2; APOPTOSIS; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; RECEPTORS, PEPTIDE; RNA, SMALL INTERFERING;

EID: 84921923257     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000369745     Document Type: Article

References (31)

1. Potente M, Gerhardt H, Carmeliet P: Basic and therapeutic aspects of angiogenesis. Cell 2011;146:873-887.
2. Adams RH, Alitalo K: Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007;8:464-478.
3. Carmeliet P: Angiogenesis in health and disease. Nat Med 2003;9:653-660.
4. Lu G, Maeda H, Reddy SV, Kurihara N, Leach R, Anderson JL, Roodman GD: Cloning and characterization of the annexin II receptor on human marrow stromal cells. J Biol Chem 2006;281:30542-30550.
5. Gerke V, Moss SE: Annexins: from structure to function. Physiol Rev 2002;82:331-371.
6. Flood EC, Hajjar KA: The annexin A2 system and vascular homeostasis. Vascul Pharmacol 2011;54:59-67.
7. Madureira PA, Surette AP, Phipps KD, Taboski MA, Miller VA, Waisman DM: The role of the annexin A2 heterotetramer in vascular fibrinolysis. Blood 2011;118:4789-4797.
8. Shiozawa Y, Havens AM, Jung Y, Ziegler AM, Pedersen EA, Wang J, Lu G, Roodman GD, Loberg RD, Pienta KJ, Taichman RS: Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem 2008;105:370-380.
9. D'Souza S, Kurihara N, Shiozawa Y, Joseph J, Taichman R, Galson DL, Roodman GD: Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment. Blood 2012;119:1888-1896.
10. Swisher JF, Burton N, Bacot SM, Vogel SN, Feldman GM: Annexin A2 tetramer activates human and murine macrophages through TLR4. Blood 2010;115:549-558.
11. Xiong Y, Fan C, Kong L, Dong L, Zhu N, Zhang J, Wang L, Qin T, Shen Y, Chen M: Annexin II receptor induces apoptosis independent of Annexin II. Apoptosis 2013;18:925-939.
12. Song H, Wang W, Zhao P, Qi Z, Zhao S: Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression. Nanoscale 2014;6:3206-3216.
13. Baumann K: Cell cycle: Making the spindle checkpoint strong. Nat Rev Mol Cell Biol 2014;15:430-430.
14. Brown JM, Attardi LD: The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 2005;5:231-237.
15. Chen ML, Lin YH, Yang CM, Hu ML: Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-Akt and ERK/p38 signaling pathways. Mol Nutr Food Res 2012;56:889-899.
16. Fang JH, Zhou HC, Zeng C, Yang J, Liu Y, Huang X, Zhang JP, Guan XY, Zhuang SM: MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology 2011;54:1729-1740.
17. Babykutty S, PS P, RJ N, Kumar M, Nair MS, Srinivas P, Gopala S: Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-κB in colon cancer cells. Mol Carcinog 2012;51:475-490.
18. Xiao L-J, Lin P, Lin F, Liu X, Qin W, Zou H-F, Guo L, Liu W, Wang S-J, Yu X-G: ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion. Int J Oncol 2012;40:1714.
19. Carmeliet P, Jain RK: Molecular mechanisms and clinical applications of angiogenesis. Nature 2011;473:298-307.
20. Lo PH, Lung HL, Cheung AK, Apte SS, Chan KW, Kwong FM, Ko JM, Cheng Y, Law S, Srivastava G, Zabarovsky ER, Tsao SW, Tang JC, Stanbridge EJ, Lung ML: Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis. Cancer Res 2010;70:5567-5576.
21. Cheung AKL, Ko JM, Lung HL, Chan KW, Stanbridge EJ, Zabarovsky E, Tokino T, Kashima L, Suzuki T, Kwong DL-W: Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-κB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis. Proc Natl Acad Sci USA 2011;108:8390-8395.
22. Law EW, Cheung AK, Kashuba VI, Pavlova TV, Zabarovsky ER, Lung HL, Cheng Y, Chua D, Lai-Wan Kwong D, Tsao SW, Sasaki T, Stanbridge EJ, Lung ML: Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma. Oncogene 2012;31:728-738.
23. Zhao S-h, Pan D-y, Zhang Y, Wu J-h, Liu X, Xu Y: Annexin A2 promotes choroidal neovascularization by increasing vascular endothelial growth factor expression in a rat model of argon laser coagulation-induced choroidal neovascularization. Chin Med J 2010;123:713.
24. Evan GI, Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-348.
25. Blagosklonny MV, Pardee AB: The restriction point of the cell cycle. Cell cycle 2002;1:102-104.
26. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T: Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003;253:269-285.
27. Kessenbrock K, Plaks V, Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010;141:52-67.
28. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-744.
29. Lambert V, Wielockx B, Munaut C, Galopin C, Jost M, Itoh T, Werb Z, Baker A, Libert C, Krell HW, Foidart JM, Noel A, Rakic JM: MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J 2003;17:2290-2292.
30. Masson V, de la Ballina LR, Munaut C, Wielockx B, Jost M, Maillard C, Blacher S, Bajou K, Itoh T, Itohara S, Werb Z, Libert C, Foidart JM, Noel A: Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J 2005;19:234-236.
31. Adya R, Tan BK, Punn A, Chen J, Randeva HS: Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovasc Res 2008;78:356-365.